Kjøller M
Kirurgisk afd, Frederiksborgs Amts Sygehus Helsingør.
Nord Med. 1990;105(11):299-300.
Ever since 1983 when Marshall & Warren succeeded in cultivating Helicobacter pylori (HP) (previously known as Campylobacter pylori) a high incidence thereof has been demonstrated in patients with ulcers and non-ulcerous dyspepsia. Helicobacter pylori is easily diagnosed via microscopy, cultivation and serological tests. The bacterium may be treated with antibiotics or the ulcer drug bismuth subcitrate (De-Nol). The pathogenetic role of HP is not clear. Some studies have shown a lower recurrence rate of duodenal ulcers after treatment addressed to Helicobacter pylori with the ulcer drug De-Nol, which suggests that HP plays a role in the onset of recurrence in cases of ulcus duodeni.
自1983年马歇尔和沃伦成功培养出幽门螺杆菌（HP）（以前称为幽门弯曲菌）以来，已证实溃疡和非溃疡性消化不良患者中该菌的发病率很高。幽门螺杆菌可通过显微镜检查、培养和血清学检测轻松诊断。该细菌可用抗生素或溃疡药物枸橼酸铋钾（得乐）治疗。幽门螺杆菌的致病作用尚不清楚。一些研究表明，用溃疡药物得乐治疗幽门螺杆菌后，十二指肠溃疡的复发率较低，这表明幽门螺杆菌在十二指肠溃疡复发中起作用。
